Revised Draft Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products

Forms and Documents

Document	Type	Status	Availability
GUIDANCE FOR USER FEE WAIVERS 7-25-11.doc	Supplementary Document	Uploaded 2011-07-26	Repair queued
GUIDANCE FOR USER FEE WAIVERS 7-25-11.doc	Supplementary Document	Uploaded 2011-07-25	Repair queued
SUPPORTING STATEMENT GUIDANCE UFWRRDBP 7-25-11 Final.doc	Supporting Statement A	Uploaded 2011-07-25	Available

IC Document Collections

IC ID	Collection	Type	Status	Form
198752	Appeal Requests	Other-guidance document	New
198751	Reconsideration Requests	Other-guidance document	New
198750	Section 736 of the FD&C Act	Other-guidance document	New

ICR Details

OMB Control No: 0910-0693	ICR Reference No: 201108-0910-004
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: HHS/FDA	Agency Tracking No:
Title: Revised Draft Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 08/16/2011
	Date Received in OIRA: 08/04/2011
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	08/31/2014	36 Months From Approved
Responses	94	0	0
Time Burden (Hours)	1,524	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: This information collection request covers the collections associated with "Revised Draft Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products," which provides recommendations to applicants considering whether to request a waiver or reduction in user fees assessed under Section 735 and 736 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act).

---

Authorizing Statute(s): US Code: 21 USC 379g and 379h Name of Law: FD&C Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	76 FR 13629	03/14/2011
30-day Notice:	Federal Register Citation:	Citation Date:
	76 FR 40375	07/18/2011
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 3

IC Title	Form No.	Form Name
Section 736 of the FD&C Act
Reconsideration Requests
Appeal Requests

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	94	0	0	94	0	0
Annual Time Burden (Hours)	1,524	0	0	1,524	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This is a new collection.

---

Annual Cost to Federal Government: $1,076,000

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 08/04/2011

---